Co-Founder
CurrentSegMedix has developed an AI-powered, web-based platform that revolutionizes prostate cancer diagnosis. The platform streamlines the diagnostic process by analyzing MRI images to segment the prostate, pinpoint lesion locations, provide a risk assessment based on the images, and generate automated radiology reports.Designed to enhance both efficiency and accuracy, the product significantly reduces the time radiologists spend on each scan while increasing their confidence in the results. By utilizing industry-standard CNN segmentation and the only web-based 3D mesh segmentation tool, the platform enables radiologists to deliver precise and reliable diagnoses.Currently, radiologists spend 20 to 45 minutes per patient’s MRI scan; with this solution, the time can be reduced to just 5 minutes, allowing more patients to be seen and improving overall workflow efficiency.
